HEADER COAGULATION FACTOR 23-AUG-96 1FAX
TITLE COAGULATION FACTOR XA INHIBITOR COMPLEX
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: FACTOR XA;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: STUART FACTOR;
COMPND 5 EC: 3.4.21.6;
COMPND 6 ENGINEERED: YES;
COMPND 7 MUTATION: YES;
COMPND 8 MOL_ID: 2;
COMPND 9 MOLECULE: FACTOR XA;
COMPND 10 CHAIN: L;
COMPND 11 SYNONYM: STUART FACTOR;
COMPND 12 EC: 3.4.21.6;
COMPND 13 ENGINEERED: YES;
COMPND 14 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 TISSUE: BLOOD;
SOURCE 6 MOL_ID: 2;
SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 8 ORGANISM_COMMON: HUMAN;
SOURCE 9 ORGANISM_TAXID: 9606;
SOURCE 10 TISSUE: BLOOD
KEYWDS GLYCOPROTEIN, HYDROLASE, SERINE PROTEASE, PLASMA, BLOOD COAGULATION
KEYWDS 2 FACTOR, GAMMA-CARBOXYGLUTAMIC ACID, CALCIUM-BINDING, COAGULATION
KEYWDS 3 FACTOR
EXPDTA X-RAY DIFFRACTION
AUTHOR H.BRANDSTETTER,R.A.ENGH
REVDAT 4 16-OCT-24 1FAX 1 REMARK SEQADV LINK
REVDAT 3 24-FEB-09 1FAX 1 VERSN
REVDAT 2 01-APR-03 1FAX 1 JRNL
REVDAT 1 29-OCT-97 1FAX 0
JRNL AUTH H.BRANDSTETTER,A.KUHNE,W.BODE,R.HUBER,W.VON DER SAAL,
JRNL AUTH 2 K.WIRTHENSOHN,R.A.ENGH
JRNL TITL X-RAY STRUCTURE OF ACTIVE SITE-INHIBITED CLOTTING FACTOR XA.
JRNL TITL 2 IMPLICATIONS FOR DRUG DESIGN AND SUBSTRATE RECOGNITION.
JRNL REF J.BIOL.CHEM. V. 271 29988 1996
JRNL REFN ISSN 0021-9258
JRNL PMID 8939944
JRNL DOI 10.1074/JBC.271.47.29988
REMARK 1
REMARK 1 REFERENCE 1
REMARK 1 AUTH H.BRANDSTETTER,M.BAUER,R.HUBER,P.LOLLAR,W.BODE
REMARK 1 TITL X-RAY STRUCTURE OF CLOTTING FACTOR IXA: ACTIVE SITE AND
REMARK 1 TITL 2 MODULE STRUCTURE RELATED TO XASE ACTIVITY AND HEMOPHILIA B
REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 92 9796 1995
REMARK 1 REFN ISSN 0027-8424
REMARK 1 REFERENCE 2
REMARK 1 AUTH K.PADMANABHAN,K.P.PADMANABHAN,A.TULINSKY,C.H.PARK,W.BODE,
REMARK 1 AUTH 2 R.HUBER,D.T.BLANKENSHIP,A.D.CARDIN,W.KISIEL
REMARK 1 TITL STRUCTURE OF HUMAN DES(1-45) FACTOR XA AT 2.2 A RESOLUTION
REMARK 1 REF J.MOL.BIOL. V. 232 947 1993
REMARK 1 REFN ISSN 0022-2836
REMARK 1 REFERENCE 3
REMARK 1 AUTH S.KATAKURA,T.NAGAHARA,T.HARA,M.IWAMOTO
REMARK 1 TITL A NOVEL FACTOR XA INHIBITOR: STRUCTURE-ACTIVITY
REMARK 1 TITL 2 RELATIONSHIPS AND SELECTIVITY BETWEEN FACTOR XA AND THROMBIN
REMARK 1 REF BIOCHEM.BIOPHYS.RES.COMMUN. V. 197 965 1993
REMARK 1 REFN ISSN 0006-291X
REMARK 2
REMARK 2 RESOLUTION. 3.00 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : X-PLOR 3.1
REMARK 3 AUTHORS : BRUNGER
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : NULL
REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL
REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 NUMBER OF REFLECTIONS : 7087
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : NULL
REMARK 3 FREE R VALUE TEST SET SELECTION : NULL
REMARK 3 R VALUE (WORKING SET) : 0.197
REMARK 3 FREE R VALUE : 0.261
REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT : NULL
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL
REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : NULL
REMARK 3 BIN FREE R VALUE : NULL
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2266
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 34
REMARK 3 SOLVENT ATOMS : 0
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM SIGMAA (A) : NULL
REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM C-V SIGMAA (A) : NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.009
REMARK 3 BOND ANGLES (DEGREES) : 2.200
REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL
REMARK 3 IMPROPER ANGLES (DEGREES) : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : NULL
REMARK 3 TOPOLOGY FILE 1 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 1FAX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 100 THE DEPOSITION ID IS D_1000173213.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 15-SEP-95
REMARK 200 TEMPERATURE (KELVIN) : NULL
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : NULL
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : NULL
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : AREA DETECTOR
REMARK 200 DETECTOR MANUFACTURER : SIEMENS
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : SAINT
REMARK 200 DATA SCALING SOFTWARE : SAINT
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL
REMARK 200 RESOLUTION RANGE HIGH (A) : NULL
REMARK 200 RESOLUTION RANGE LOW (A) : NULL
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : NULL
REMARK 200 DATA REDUNDANCY : 5.600
REMARK 200 R MERGE (I) : 0.11800
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: NULL
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL
REMARK 200 SOFTWARE USED: X-PLOR 3.1
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 41.84
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: NULL
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.46500
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.54000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.58500
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 39.54000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.46500
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.58500
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 2720 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 13740 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, L
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 400
REMARK 400 COMPOUND
REMARK 400 EGF1 DOMAIN IS DISORDERED IN THE CRYSTAL.
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 246
REMARK 465 LEU A 247
REMARK 465 PRO A 248
REMARK 465 LYS A 249
REMARK 465 ALA A 250
REMARK 465 LYS A 251
REMARK 465 SER A 252
REMARK 465 HIS A 253
REMARK 465 ALA A 254
REMARK 465 PRO A 255
REMARK 465 GLU A 256
REMARK 465 VAL A 257
REMARK 465 ILE A 258
REMARK 465 THR A 259
REMARK 465 SER A 260
REMARK 465 SER A 261
REMARK 465 PRO A 262
REMARK 465 LEU A 263
REMARK 465 LYS A 264
REMARK 465 TYR L 44
REMARK 465 LYS L 45
REMARK 465 ASP L 46
REMARK 465 GLY L 47
REMARK 465 ASP L 48
REMARK 465 GLN L 49
REMARK 465 CYS L 50
REMARK 465 GLU L 51
REMARK 465 THR L 52
REMARK 465 SER L 53
REMARK 465 PRO L 54
REMARK 465 CYS L 55
REMARK 465 GLN L 56
REMARK 465 ASN L 57
REMARK 465 GLN L 58
REMARK 465 GLY L 59
REMARK 465 LYS L 60
REMARK 465 CYS L 61
REMARK 465 LYS L 62
REMARK 465 ASP L 63
REMARK 465 GLY L 64
REMARK 465 LEU L 65
REMARK 465 GLY L 66
REMARK 465 GLU L 67
REMARK 465 TYR L 68
REMARK 465 THR L 69
REMARK 465 CYS L 70
REMARK 465 THR L 71
REMARK 465 CYS L 72
REMARK 465 LEU L 73
REMARK 465 GLU L 74
REMARK 465 GLY L 75
REMARK 465 PHE L 76
REMARK 465 GLU L 77
REMARK 465 GLY L 78
REMARK 465 LYS L 79
REMARK 465 ASN L 80
REMARK 465 CYS L 81
REMARK 465 GLU L 82
REMARK 465 LEU L 83
REMARK 465 PHE L 84
REMARK 480
REMARK 480 ZERO OCCUPANCY ATOM
REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO
REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS
REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME;
REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 480 M RES C SSEQI ATOMS
REMARK 480 ARG A 63 CB CG CD NE CZ NH1 NH2
REMARK 480 ARG A 150 CB CG CD NE CZ NH1 NH2
REMARK 480 LYS A 243 NZ
REMARK 480 ARG A 245 O CB CG CD NE CZ NH1
REMARK 480 ARG A 245 NH2
REMARK 480 LYS L 87 CB CG CD CE NZ
REMARK 480 LEU L 91 CB CG CD1 CD2
REMARK 480 ASP L 92 OD1 OD2
REMARK 480 HIS L 101 CG ND1 CD2 CE1 NE2
REMARK 480 GLU L 102 OE2
REMARK 480 GLU L 103 CG CD OE1 OE2
REMARK 480 GLN L 104 CB CG CD OE1 NE2
REMARK 480 ALA L 105 CA C O CB
REMARK 480 ARG L 113 NH2
REMARK 480 ASP L 119 OD1 OD2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 TRP A 127 CA - C - N ANGL. DEV. = -13.3 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ALA A 56 -59.78 -15.82
REMARK 500 GLU A 77 33.06 -82.20
REMARK 500 ASN A 92 -10.88 -44.56
REMARK 500 PHE A 94 103.81 -57.88
REMARK 500 ASN A 117 10.14 89.77
REMARK 500 PRO A 124 -166.38 -78.56
REMARK 500 TRP A 127 73.70 81.87
REMARK 500 ALA A 128 -70.99 165.80
REMARK 500 SER A 130 148.78 76.66
REMARK 500 THR A 131 -76.38 66.04
REMARK 500 ARG A 143 130.88 -36.71
REMARK 500 HIS A 145 -2.47 -156.47
REMARK 500 GLU A 147 119.63 63.98
REMARK 500 GLN A 151 -86.27 -68.77
REMARK 500 SER A 152 -54.59 -160.24
REMARK 500 THR A 153 -51.98 69.45
REMARK 500 GLN A 178 3.00 -67.56
REMARK 500 ASP A 189 160.41 174.31
REMARK 500 ASP A 205 -20.01 66.94
REMARK 500 SER A 214 -75.91 -102.94
REMARK 500 LYS A 223 107.87 -57.63
REMARK 500 THR A 244 99.46 107.51
REMARK 500 LYS L 87 -168.99 178.32
REMARK 500 LEU L 88 98.32 74.44
REMARK 500 SER L 90 -71.59 -66.73
REMARK 500 LEU L 91 -65.60 -8.60
REMARK 500 ASP L 92 57.24 -163.73
REMARK 500 GLN L 98 -108.68 -133.26
REMARK 500 GLN L 104 -80.87 64.58
REMARK 500 VAL L 108 98.97 61.93
REMARK 500 LYS L 122 -44.84 -132.13
REMARK 500
REMARK 500 REMARK: NULL
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 CA A 1 CA
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 ASP A 70 OD1
REMARK 620 2 ASN A 72 O 65.8
REMARK 620 3 ALA A 75 O 162.8 122.0
REMARK 620 4 GLU A 80 OE2 82.2 130.8 81.7
REMARK 620 5 GLU A 80 OE1 71.7 135.2 102.7 52.5
REMARK 620 N 1 2 3 4
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: CAT
REMARK 800 EVIDENCE_CODE: UNKNOWN
REMARK 800 SITE_DESCRIPTION: CATALYTIC CENTER OF SERINE PROTEASE.
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 1
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DX9 A 265
DBREF 1FAX A 16 264 UNP P00742 FA10_HUMAN 235 481
DBREF 1FAX L 44 139 UNP P00742 FA10_HUMAN 84 179
SEQADV 1FAX ALA A 74 UNP P00742 GLU 294 CONFLICT
SEQADV 1FAX ALA A 75 UNP P00742 GLN 295 CONFLICT
SEQADV 1FAX ALA L 105 UNP P00742 ASN 145 CONFLICT
SEQRES 1 A 254 ILE VAL GLY GLY GLN GLU CYS LYS ASP GLY GLU CYS PRO
SEQRES 2 A 254 TRP GLN ALA LEU LEU ILE ASN GLU GLU ASN GLU GLY PHE
SEQRES 3 A 254 CYS GLY GLY THR ILE LEU SER GLU PHE TYR ILE LEU THR
SEQRES 4 A 254 ALA ALA HIS CYS LEU TYR GLN ALA LYS ARG PHE LYS VAL
SEQRES 5 A 254 ARG VAL GLY ASP ARG ASN THR ALA ALA GLU GLU GLY GLY
SEQRES 6 A 254 GLU ALA VAL HIS GLU VAL GLU VAL VAL ILE LYS HIS ASN
SEQRES 7 A 254 ARG PHE THR LYS GLU THR TYR ASP PHE ASP ILE ALA VAL
SEQRES 8 A 254 LEU ARG LEU LYS THR PRO ILE THR PHE ARG MET ASN VAL
SEQRES 9 A 254 ALA PRO ALA CYS LEU PRO GLU ARG ASP TRP ALA GLU SER
SEQRES 10 A 254 THR LEU MET THR GLN LYS THR GLY ILE VAL SER GLY PHE
SEQRES 11 A 254 GLY ARG THR HIS GLU LYS GLY ARG GLN SER THR ARG LEU
SEQRES 12 A 254 LYS MET LEU GLU VAL PRO TYR VAL ASP ARG ASN SER CYS
SEQRES 13 A 254 LYS LEU SER SER SER PHE ILE ILE THR GLN ASN MET PHE
SEQRES 14 A 254 CYS ALA GLY TYR ASP THR LYS GLN GLU ASP ALA CYS GLN
SEQRES 15 A 254 GLY ASP SER GLY GLY PRO HIS VAL THR ARG PHE LYS ASP
SEQRES 16 A 254 THR TYR PHE VAL THR GLY ILE VAL SER TRP GLY GLU GLY
SEQRES 17 A 254 CYS ALA ARG LYS GLY LYS TYR GLY ILE TYR THR LYS VAL
SEQRES 18 A 254 THR ALA PHE LEU LYS TRP ILE ASP ARG SER MET LYS THR
SEQRES 19 A 254 ARG GLY LEU PRO LYS ALA LYS SER HIS ALA PRO GLU VAL
SEQRES 20 A 254 ILE THR SER SER PRO LEU LYS
SEQRES 1 L 96 TYR LYS ASP GLY ASP GLN CYS GLU THR SER PRO CYS GLN
SEQRES 2 L 96 ASN GLN GLY LYS CYS LYS ASP GLY LEU GLY GLU TYR THR
SEQRES 3 L 96 CYS THR CYS LEU GLU GLY PHE GLU GLY LYS ASN CYS GLU
SEQRES 4 L 96 LEU PHE THR ARG LYS LEU CYS SER LEU ASP ASN GLY ASP
SEQRES 5 L 96 CYS ASP GLN PHE CYS HIS GLU GLU GLN ALA SER VAL VAL
SEQRES 6 L 96 CYS SER CYS ALA ARG GLY TYR THR LEU ALA ASP ASN GLY
SEQRES 7 L 96 LYS ALA CYS ILE PRO THR GLY PRO TYR PRO CYS GLY LYS
SEQRES 8 L 96 GLN THR LEU GLU ARG
HET CA A 1 1
HET DX9 A 265 39
HETNAM CA CALCIUM ION
HETNAM DX9 (2S)-3-(7-CARBAMIMIDOYLNAPHTHALEN-2-YL)-2-[4-({(3R)-1-
HETNAM 2 DX9 [(1Z)-ETHANIMIDOYL]PYRROLIDIN-3-YL}OXY)
HETNAM 3 DX9 PHENYL]PROPANOIC ACID
HETSYN DX9 DX9056A
FORMUL 3 CA CA 2+
FORMUL 4 DX9 C26 H28 N4 O3
HELIX 1 1 ALA A 56 TYR A 60 5 5
HELIX 2 2 ARG A 165 SER A 171 1 7
HELIX 3 3 VAL A 231 ALA A 233 5 3
HELIX 4 4 LEU A 235 LYS A 243 1 9
HELIX 5 5 ASN L 93 ASP L 95 5 3
SHEET 1 A 4 ALA A 81 GLU A 84 0
SHEET 2 A 4 PHE A 64 VAL A 68 -1 N VAL A 68 O ALA A 81
SHEET 3 A 4 GLN A 30 ASN A 35 -1 N ILE A 34 O LYS A 65
SHEET 4 A 4 GLY A 40 THR A 45 -1 N GLY A 44 O ALA A 31
SHEET 1 B 3 TYR A 51 THR A 54 0
SHEET 2 B 3 ALA A 104 LEU A 108 -1 N LEU A 106 O ILE A 52
SHEET 3 B 3 VAL A 85 LYS A 90 -1 N ILE A 89 O VAL A 105
SHEET 1 C 2 THR A 135 GLY A 140 0
SHEET 2 C 2 LYS A 156 PRO A 161 -1 N VAL A 160 O GLY A 136
SHEET 1 D 4 MET A 180 ALA A 183 0
SHEET 2 D 4 GLY A 226 LYS A 230 -1 N TYR A 228 O PHE A 181
SHEET 3 D 4 THR A 206 GLY A 216 -1 N TRP A 215 O ILE A 227
SHEET 4 D 4 PRO A 198 PHE A 203 -1 N PHE A 203 O THR A 206
SHEET 1 E 2 TYR L 115 LEU L 117 0
SHEET 2 E 2 CYS L 124 PRO L 126 -1 N ILE L 125 O THR L 116
SSBOND 1 CYS A 22 CYS A 27 1555 1555 2.02
SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.01
SSBOND 3 CYS A 122 CYS L 132 1555 1555 2.02
SSBOND 4 CYS A 168 CYS A 182 1555 1555 2.01
SSBOND 5 CYS A 191 CYS A 220 1555 1555 2.01
SSBOND 6 CYS L 89 CYS L 100 1555 1555 2.02
SSBOND 7 CYS L 96 CYS L 109 1555 1555 2.02
SSBOND 8 CYS L 111 CYS L 124 1555 1555 2.02
LINK CA CA A 1 OD1 ASP A 70 1555 1555 2.96
LINK CA CA A 1 O ASN A 72 1555 1555 1.99
LINK CA CA A 1 O ALA A 75 1555 1555 2.28
LINK CA CA A 1 OE2 GLU A 80 1555 1555 2.12
LINK CA CA A 1 OE1 GLU A 80 1555 1555 2.65
SITE 1 CAT 3 HIS A 57 ASP A 102 SER A 195
SITE 1 AC1 5 ASP A 70 ASN A 72 ALA A 75 GLU A 77
SITE 2 AC1 5 GLU A 80
SITE 1 AC2 9 GLU A 97 ASP A 189 ALA A 190 CYS A 191
SITE 2 AC2 9 GLN A 192 TRP A 215 GLY A 216 GLY A 218
SITE 3 AC2 9 GLY A 226
CRYST1 56.930 73.170 79.080 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.017565 0.000000 0.000000 0.00000
SCALE2 0.000000 0.013667 0.000000 0.00000
SCALE3 0.000000 0.000000 0.012645 0.00000